Type 1 diabetes mellitus

Related records

Broader conditions (15)

• Autoimmune disease
• Autoimmune disorder of endocrine system
• Autoimmune disorder of gastrointestinal tract
• Diabetes mellitus
• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Endocrine pancreas disorder
• Endocrine system disorder
• Glucose metabolism disease
• Human disease
• Immune system disorder
• Metabolic disease
• Pancreas disorder

Narrower conditions (1)

• Latent autoimmune diabetes in adults

Trials (3,830)

• ¿Can mySugr App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus?
• "FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)
• "MiniMed 640G System" User Evaluation With the Question of Reducing the Rate of Hypoglycemia
• "MyPlan" - Individualized Planned Eating Patterns for Adolescents With Type 1 Diabetes
• "Perception, Knowledge, and Attitudes of Educational Staff Regarding the Care of Children With Type 1 Diabetes: Evaluation of the Educational Program"
• "POWER2DM Evaluation Campaign"
• "Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"
• "Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"
• 11C-5-HTP PET in Clinical Islet Transplantation
• 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
• 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus
• 24-hour Movement Behaviors in Adults With Type 1 Diabetes
• 24/7 Closed-loop in Older Subjects With Type 1 Diabetes
• 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus
• 4T Sustainability Program
• 5-MTHF Supplementation for Treatment of Type 1 Diabetes Patients
• 52 Week Trial of Liraglutide in Type 1 Diabetes
• 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes
• A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)
• A 2-Month Safety Follow-Up Trial

Approved drugs (6)

• Dasiglucagon hydrochloride
• Insulin detemir
• Insulin glargine
• Insulin icodec
• Sotagliflozin
• Teplizumab

Drugs in development (322)

• .ALPHA.1-proteinase inhibitor human Phase 2
• Abatacept Phase 2
• Abrocitinib Phase 2
• Acetaminophen Phase 2
• Acetazolamide Phase 1
• Acipimox Phase 3
• Adakitug Phase 1
• Adalimumab Phase 1
• Adomeglivant Phase 1
• Afasevikumab Phase 1
• Alagebrium Phase 2
• Albiglutide Phase 2
• Aldesleukin Phase 2
• Alefacept Phase 2
• Alemtuzumab Phase 2
• Alirocumab Phase 3
• Almagate Phase 2
• Alprazolam Phase 1
• Aluminum hydroxide Phase 2
• Amitriptyline Phase 2

Other linked drugs (34)

• Adenosine
• Alanine
• Aspartic acid
• Avexitide
• Beta carotene
• Carnitine
• Clotrimazole
• CO-trimoxazole
• Colesevelam hydrochloride
• Darbepoetin alfa
• Dexamethasone
• Diazoxide
• Epinephrine
• Epoetin alfa
• Epoetin beta
• Ferumoxytol
• Fludrocortisone
• Formoterol
• Glutamine
• Levomefolic acid